… our experts teams are here to support your developments of mAbs , ADCs and proteins.   12 years’ experience with CBMPs: …

… regulatory landscape, the physico-chemical and biological  characterisation of viral vector-based products is … designed to instruct patients’ own cells to produce a protein that can treat, cure or prevent diseases. mRNA … infectious diseases, as cancer immunotherapy, and as protein replacement therapy for rare diseases. Building on …

… 2:00PM,  Géry Van Vyncht will present on Therapeutic Protein Charge Variant Characterization with Intact Mass and … are here to support your developments of mAbs , ADCs and proteins.   11 years’ experience with CBMPs: Cell-Based … regulatory landscape, the physicochemical and biological characterisation of viral vector-based products is …

… ( mAbs ,  ADCs ) NCEs ,  oligonucleotides ,  peptides mRNA Viral vectors Vaccines Cell-based medicinal …